라트비아 -
라트비아어 -
Zāļu valsts aģentūra
arduan 4 mg pulveris un šķīdinātājs injekciju šķīduma pagatavošanai
gedeon richter plc., hungary - pipekuronija bromīds - pulveris un šķīdinātājs injekciju šķīduma pagatavošanai - 4 mg
라트비아 -
라트비아어 -
Zāļu valsts aģentūra
nivalin 10 mg/ml šķīdums injekcijām
sopharma ad, bulgaria - galantamīna hidrobromīds - Šķīdums injekcijām - 10 mg/ml
라트비아 -
라트비아어 -
Zāļu valsts aģentūra
nivalin 10 mg tabletes
sopharma ad, bulgaria - galantamīna hidrobromīds - tablete - 10 mg
라트비아 -
라트비아어 -
Zāļu valsts aģentūra
nivalin 5 mg tabletes
sopharma ad, bulgaria - galantamīna hidrobromīds - tablete - 5 mg
라트비아 -
라트비아어 -
Zāļu valsts aģentūra
nivalin 5 mg/ml šķīdums injekcijām
sopharma ad, bulgaria - galantamīna hidrobromīds - Šķīdums injekcijām - 5 mg/ml
라트비아 -
라트비아어 -
Zāļu valsts aģentūra
nivalin 2,5 mg/ml šķīdums injekcijām
sopharma ad, bulgaria - galantamīna hidrobromīds - Šķīdums injekcijām - 2,5 mg/ml
유럽 연합 -
라트비아어 -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
유럽 연합 -
라트비아어 -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
유럽 연합 -
라트비아어 -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neiromuskulārā blokāde - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
유럽 연합 -
라트비아어 -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.